Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BEKE-W
02423
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -13.57%1.76B | -13.02%1.17B | -15.96%545.83M | -28.51%2.79B | -31.49%2.04B | -33.52%1.35B | -30.40%649.49M | -10.58%3.9B | -9.72%2.98B | -6.80%2.02B |
| Refunds of taxes and levies | -90.10%43.38K | ---- | ---- | 107.94%437.94K | 107.94%437.94K | 107.94%437.94K | ---- | -98.36%210.61K | --210.61K | --210.61K |
| Cash received relating to other operating activities | -35.21%182.28M | -35.97%120.06M | -34.87%59.09M | -40.78%393.48M | -44.14%281.36M | -47.44%187.52M | -57.62%90.71M | -45.94%664.44M | -48.37%503.69M | -42.01%356.79M |
| Cash inflows from operating activities | -16.21%1.95B | -15.85%1.29B | -18.28%604.92M | -30.29%3.18B | -33.31%2.32B | -35.59%1.53B | -35.48%740.2M | -18.53%4.57B | -18.53%3.48B | -14.57%2.38B |
| Goods services cash paid | -6.96%37.53M | -2.66%26.14M | -3.75%14.32M | -39.29%56.78M | -46.07%40.34M | -51.68%26.85M | -61.88%14.88M | -64.32%93.53M | -61.73%74.8M | -58.12%55.57M |
| Staff behalf paid | -16.80%709.46M | -18.20%497.47M | -17.32%295.56M | -23.68%1.07B | -23.30%852.76M | -18.67%608.15M | -14.83%357.46M | -13.88%1.4B | -15.61%1.11B | -17.26%747.71M |
| All taxes paid | -10.68%84.37M | -6.22%63.17M | -21.19%27.18M | -26.05%121.01M | -25.08%94.45M | -26.47%67.36M | -15.80%34.49M | -32.25%163.63M | -38.67%126.07M | -44.08%91.62M |
| Cash paid relating to other operating activities | -21.85%1.12B | -19.91%762.28M | -21.57%378.29M | -23.98%1.87B | -23.10%1.44B | -24.50%951.78M | -19.37%482.32M | -13.54%2.46B | -16.20%1.87B | -9.50%1.26B |
| Cash outflows from operating activities | -19.39%1.95B | -18.44%1.35B | -19.55%715.36M | -24.31%3.12B | -23.79%2.42B | -23.26%1.65B | -19.01%889.15M | -17.24%4.12B | -19.43%3.18B | -16.88%2.16B |
| Net cash flows from operating activities | 93.74%-6.23M | 51.28%-59M | 25.86%-110.44M | -85.23%66.24M | -132.63%-99.52M | -153.90%-121.1M | -401.99%-148.95M | -28.78%448.5M | -7.77%304.98M | 16.49%224.68M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 2,449.02%33.8M | 2,449.02%33.8M | 186.58%3.8M | -67.26%1.33M | -67.26%1.33M | -61.90%1.33M | -50.89%1.33M | -97.85%4.05M | 146.77%4.05M | 575.33%3.48M |
| Cash received from returns on investments | 37.62%1.09M | 47.60%1.09M | 6.01%655.27K | 0.92%792.26K | 0.92%792.26K | -0.39%738.69K | -16.64%618.15K | -85.74%785K | -85.67%785K | --741.55K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 376.95%32.17M | 819.64%26.04M | 2,727.05%21.38M | 36.79%16.58M | -28.94%6.74M | -65.12%2.83M | -88.19%756.37K | -42.38%12.12M | -42.35%9.49M | 1.60%8.12M |
| Net cash received from disposal of subsidiaries and other business units | --0 | ---- | ---- | -100.00%1 | ---- | ---- | ---- | -99.64%35.54K | -99.66%35.54K | -99.66%35.54K |
| Cash received relating to other investing activities | -18.70%138.4M | --33.2M | --33.2M | ---- | --170.23M | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 14.72%205.45M | 1,822.34%94.13M | 2,085.99%59.03M | 10.04%18.69M | 1,147.06%179.09M | -60.43%4.9M | -72.57%2.7M | -92.44%16.99M | -57.98%14.36M | -35.20%12.38M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 191.90%6.08M | 230.36%3.23M | 758.86%1.82M | -15.27%4.48M | -43.24%2.08M | -66.52%977.93K | -88.17%211.61K | -89.47%5.29M | -70.45%3.67M | -49.39%2.92M |
| Cash paid to acquire investments | --340K | --190K | ---- | ---- | ---- | ---- | ---- | 2.41%4.05M | -27.97%2.85M | -69.38%245K |
| Cash paid relating to other investing activities | -20.91%350.26M | -47.49%110.36M | ---- | -3.72%299.11M | 77.15%442.87M | --210.17M | --60M | 637.40%310.67M | 493.39%250M | ---- |
| Cash outflows from investing activities | -19.84%356.68M | -46.11%113.78M | -96.98%1.82M | -5.13%303.59M | 73.46%444.95M | 6,570.09%211.15M | 3,265.49%60.21M | 232.32%320M | 338.47%256.52M | -90.76%3.17M |
| Net cash flows from investing activities | 43.12%-151.23M | 90.47%-19.65M | 199.49%57.22M | 5.98%-284.9M | -9.79%-265.86M | -2,339.37%-206.25M | -813.82%-57.51M | -335.70%-303.01M | -895.44%-242.15M | 160.75%9.21M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 5,910.00%2.94M | 4,110.00%2.06M | --735K | -97.58%49K | -93.85%49K | -93.85%49K | ---- | -74.78%2.02M | --797K | --797K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 5,910.00%2.94M | 4,110.00%2.06M | --735K | -97.58%49K | -93.85%49K | -93.85%49K | ---- | -74.78%2.02M | --797K | --797K |
| Cash from borrowing | -90.48%2M | ---- | ---- | -94.20%21.5M | -94.34%21M | -94.33%21M | ---- | 67.94%371M | 68.98%371.31M | 68.48%370.21M |
| Cash received relating to other financing activities | ---- | ---- | ---- | 30.01%406.94K | --406.94K | --388.44K | --159.25K | -42.93%313K | ---- | ---- |
| Cash inflows from financing activities | -76.95%4.94M | -90.38%2.06M | 361.54%735K | -94.12%21.96M | -94.23%21.46M | -94.22%21.44M | -99.91%159.25K | 62.69%373.33M | 69.34%372.11M | 68.84%371.01M |
| Borrowing repayment | -86.03%21M | -86.03%21M | ---- | -76.27%150.8M | -69.69%150.3M | -58.57%150.3M | 4,773.59%150.3M | 49.75%635.5M | 29.39%495.88M | 106.68%362.78M |
| Dividend interest payment | -65.45%9.5M | -12.21%7.01M | 131.98%2.14M | -24.28%33.76M | -34.77%27.49M | -75.38%7.99M | -95.44%922.7K | -18.25%44.59M | -7.38%42.15M | 24.26%32.43M |
| -Including:Cash payments for dividends or profit to minority shareholders | -64.94%9.26M | -3.75%6.78M | --2.01M | 83.50%32.55M | 50.40%26.41M | -38.09%7.04M | ---- | 2.26%17.74M | 30.86%17.56M | 1,044.64%11.37M |
| Cash payments relating to other financing activities | -79.09%9.15M | -78.97%6.62M | -54.12%4.24M | -90.93%39.14M | -89.61%43.73M | -91.89%31.47M | -97.53%9.24M | 149.22%431.48M | 188.73%420.7M | 216.93%388.04M |
| Cash outflows from financing activities | -82.10%39.64M | -81.75%34.63M | -96.02%6.38M | -79.88%223.7M | -76.89%221.52M | -75.77%189.76M | -59.60%160.46M | 70.48%1.11B | 66.90%958.72M | 141.69%783.26M |
| Net cash flows from financing activities | 82.66%-34.7M | 80.65%-32.57M | 96.48%-5.65M | 72.67%-201.74M | 65.90%-200.06M | 59.17%-168.32M | 29.34%-160.3M | -74.70%-738.23M | -65.38%-586.61M | -295.12%-412.25M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -1,294.50%-44.93K | -1,505.22%-64.93K | -648.46%-2.16K | -64.86%13.67K | -103.54%-3.22K | -95.15%4.62K | 102.16%393.69 | 159.51%38.9K | -9.61%91.06K | 108.09%95.25K |
| Net increase in cash and cash equivalents | 66.01%-192.2M | 77.55%-111.28M | 83.95%-58.87M | 29.07%-420.39M | -7.97%-565.45M | -178.04%-495.66M | -116.39%-366.77M | -276.56%-592.71M | -985.44%-523.69M | -342.81%-178.27M |
| Add:Begin period cash and cash equivalents | -26.60%1.16B | -26.60%1.16B | -26.60%1.16B | -27.27%1.58B | -27.27%1.58B | -27.27%1.58B | -27.27%1.58B | 18.27%2.17B | 18.27%2.17B | 18.27%2.17B |
| End period cash equivalent | -4.64%967.93M | -3.32%1.05B | -9.27%1.1B | -26.60%1.16B | -38.46%1.02B | -45.62%1.08B | -39.43%1.21B | -27.27%1.58B | -7.81%1.65B | 4.40%1.99B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.